Pharmaceutical Regulation and Health Policy Objectives
نویسندگان
چکیده
منابع مشابه
Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
INTRODUCTION Policy-makers worldwide struggle to balance health with industrial policy objectives in the pharmaceutical sector. Tensions arise over pricing and reimbursement in particular. What health plans view as necessary to maintain equitable access to medicines, industry views as inimical to R&D and innovation. Australia has grappled with this issue for years, even incorporating the goal o...
متن کاملPharmaceutical Price Control Policy, Pharmaceutical Innovation, and Health Durability
Background: The increase in R&D and upward trend of R&D/pharmaceutical sales has occurred despite government controlled pharmaceutical price reduction in Japan. This paper identifies the effect of the government’s price control policy on pharmaceutical innovation and evaluates the influence of new chemical entities (NCE) on health
متن کاملProduct listing agreements (PLAs): a new tool for reaching Quebec's pharmaceutical policy objectives?
Product listing agreements (PLAs) with pharmaceutical manufacturers are increasingly viewed as an innovative and useful tool in the effort to control drug expenditures. To date, Quebec is the only province that has been reluctant to enter into such agreements, arguing that their confidential nature may lead to a disparity in coverage between individuals covered by the public plan and those cove...
متن کاملPublic Policy and Pharmaceutical Innovation
Historically, new drug introductions have played a central role in medical progress and the availability of cost-effective therapies. Nevertheless, public policy toward pharmaceuticals has been characterized in recent times by increasingly stringent regulatory controls, shorter effective patent terms, and increased encouragement of generic product usage. This has had an adverse effect on the in...
متن کاملPharmaceutical expenditure forecast model to support health policy decision making
BACKGROUND AND OBJECTIVE With constant incentives for healthcare payers to contain their pharmaceutical budgets, modelling policy decision impact became critical. The objective of this project was to test the impact of various policy decisions on pharmaceutical budget (developed for the European Commission for the project 'European Union (EU) Pharmaceutical expenditure forecast' - http://ec.eur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: SSRN Electronic Journal
سال: 2013
ISSN: 1556-5068
DOI: 10.2139/ssrn.2371095